Torrent Pharmaceuticals Limited (TORNTPHARM) — Board Meeting | 1 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Independent Director Ameera Shah's term ended on 01-Aug-2026
💡 Investor Takeaway
This ends Shah's independent directorship without impacting ongoing governance or strategic plans.

Torrent Pharmaceuticals announced the cessation of Ameera Shah as an Independent Director effective 01-Aug-2026, following completion of her term as per SEBI Listing Regulations. The change is documented in Annexure A of the filing.

📄 View Original Announcement (PDF)

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TORNTPHARM — Free

Free account · 2 AI queries/day